Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Plan zero based budgets for families to create a shared financial vision, allocate funds, and pursue common goals together.
19,813 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A three-week ban on Anthropic's AI services by U.S. regulators ended, igniting a debate over whether the episode coul...
A leading market strategist warns that yen carry-trade unwinds and weakness in Korea's KOSPI could foreshadow broader...
Base edges Ethereum in June's adjusted stablecoin volume, signaling a shift in crypto payments rails and spotlighting...
AngelList is terminating its Rail partnership with Ripple, ending crypto payments on the platform by July 31, 2026. T...
Pump.fun’s PUMP token faces a major insider unlock totaling $127 million. If insiders hold, liquidity may hold; if th...
Schwab strategists warn major shifts are underway as volatility rises and policy tightens, signaling an era change fo...
Fraud investigators warn that bitcoin atms becoming last stop in a sprawling scam network. New data show 2025 losses ...
A former Central Colorado parcel near Salida is being developed into a 55-acre, 106-home 3D-printed community, testin...
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
SpaceX held firm through a choppy month, outperforming peers in the space stock group. The market’s rotation favored ...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...